Assistant Professor, Surgery, Duke University School of Medicine
Thoracic Surgery
Dr. Mark F. Berry, MD
|
|
Give Review
Mark Berry works in the field of Thoracic Surgery. He graduated from Perelman School of Medicine at the University of Pennsylvania. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Mark Berry is also published. He has 68 publications published. The lastest publication: "Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.' Dr. Mark F. Berry accepts all Medicare patients.
Publications
- Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base.
- Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
- The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung Cancer.
- Pulmonary Artery Bleeding During Video-Assisted Thoracoscopic Surgery: Intraoperative Bleeding and Control.
- Cardiovascular comorbidities and survival of lung Cancer patients: Medicare data based analysis.
- Hyperbaric oxygen therapy for treatment of neurologic sequela after atrioEsophageal fistula.
- Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
- Defining the Role of Adjuvant Chemotherapy After Lobectomy for Typical Bronchopulmonary Carcinoid Tumors.
- The Prognostic Importance of the Number of Dissected Lymph Nodes After Induction Chemoradiotherapy for Esophageal Cancer.
- Use of amiodarone after major Lung resection.
- Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung Cancer: Implications for stereotactic body radiation t...
- Thoracoscopic left upper lobectomy in patients with internal mammary Artery coronary bypass grafts.
- Impact of Pretreatment Imaging on Survival of Esophagectomy After Induction Therapy for Esophageal Cancer: Who Should be Given the Benefit of the Doubt? : Esophagectom...
- Benefit of Adjuvant Chemotherapy After Resection of Stage II (T1-2N1M0) Non-Small Cell Lung Cancer in Elderly Patients.
- Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for Esophageal cancer.
- Outcomes after treatment of 17 378 patients with locally advanced (T3N0-2) non-small-cell lung Cancerâ
- Thoracoscopic Approach to Lobectomy for Lung Cancer Does Not Compromise Oncologic Efficacy.
- Esophageal cancer: staging system and guidelines for staging and treatment.
- Discrete Improvement in Racial Disparity in Survival among Patients with Stage IV Colorectal Cancer: a 21-Year Population-Based Analysis.
- Role of segmentectomy for Pulmonary metastases.
- Surgical Management of Congenital Pulmonary Malformations After the First Decade of Life.
- Sleeve Lobectomy for Non-Small Cell Lung Cancer With N1 Nodal Disease Does Not Compromise Survival.
- The impact of pulmonary hypertension on morbidity and mortality following major Lung resection.
- Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced Esophageal cancer: a propensity score adjusted analysis of the surveillan...
- Contraindications of video-assisted thoracoscopic surgical lobectomy and determinants of conversion to open.
- Treatment Modalities for T1N0 Esophageal Cancers: A Comparative Analysis of Local Therapy Versus Surgical Resection.
- Does Pneumonectomy Have a Role in the Treatment of Stage IIIA Non-Small Cell Lung Cancer?
- Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non-Small-Cell Lung Cancer.
- The Role of Radiation Therapy in Resected T2 N0 Esophageal Cancer: A Population-Based Analysis.
- Impact of T status and N status on perioperative outcomes after thoracoscopic lobectomy for lung Cancer.
- Does surgery improve outcomes for Esophageal squamous cell carcinoma? An analysis using the surveillance epidemiology and end results registry from 1998 to 2008.
- Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung Cancer.
- Outcomes after surgical management of synchronous bilateral primary lung Cancers.
- Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection.
- Persistent N2 Disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
- Perioperative Management of Patients on Clopidogrel (Plavix) Undergoing Major Lung Resection.
- Incorporating research into thoracic surgery practice.
- A comprehensive evaluation for aspiration after esophagectomy reduces the incidence of postoperative pneumonia.
- Cardiac angiosarcoma presenting with right coronary artery pseudoAneurysm.
- Giant thoracic liposarcoma treated with induction chemotherapy followed by surgical resection.
- Repair of large complex recurrent incisional hernias with retromuscular mesh and panniculectomy.
- Complications of thoracoscopic Pulmonary resection.
- Placental growth factor provides a novel local angiogenic therapy for ischemic Cardiomyopathy.
- Chest wall/diaphragmatic complications.
- Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance.
- Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic Cardiomyopathy.
- Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic Heart failure.
- Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction Heart failure.
- Apelin has in vivo inotropic effects on normal and failing Hearts.
- Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic Cardiomyopathy.
- Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
- Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
- Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia.
- Repair of acute type A Aortic dissection associated with temporal arteritis.
- Gene transfer of hepatocyte growth factor attenuates postinfarction Heart failure.
- Dexon mesh splenorrhaphy for intraoperative splenic injuries.
- A model for morbidity after Lung resection in octogenarians.
- Risk factors for morbidity after lobectomy for lung Cancer in elderly patients.
- Pulmonary function tests do not predict Pulmonary complications after thoracoscopic lobectomy.
- Ischemic Heart failure enhances endogenous myocardial apelin and APJ receptor expression.
- Neovasculogenic therapy to augment perfusion and preserve viability in ischemic Cardiomyopathy.
- Neurological monitoring and off-pump surgery in a very high-risk stroke patient.
- Ethyl pyruvate enhances ATP levels, reduces oxidative stress and preserves cardiac function in a rat model of off-pump Coronary bypass.
- Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
- Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic Cardiomyopathy.
- Creatine phosphate administration preserves myocardial function in a model of off-pump Coronary revascularization.
- Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas.
Schools
Perelman School of Medicine University of Pennsylvania
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Chest CT (incl. Heart and Lungs)
- Decortication and Pleurectomy
- View All
Conditions Treated
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiac Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
University of Pennsylvania Health System -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Stanford Health Care
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356508048 |
| Last Name Of The Provider | BERRY |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Zachary E. Brewer, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank Hanley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James I. Fann, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael P. Fischbein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bryan M. Burt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard-Tien V. Ha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert Robbins, MD |
|
|
Dr. Jayan Nagendran, MD |
|
|
Dr. Bruce Reitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. R S. Mitchell, MD |
|
|
Dr. Richard Mainwaring, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gabriel Amir, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Olaf Reinhartz, MD
This Doctor is OpenDoctor Recommended.
|